Lateral Flow Assays Market Growth, Industry Share, Forecast, 2030

Lateral Flow Assays Market offers rapid, low-cost diagnostic testing across healthcare, veterinary and food-safety sectors—driven by rising demand for point-of-care solutions and infectious disease detection.

Lateral Flow Assays Market Size

Market Overview

Lateral flow assays are devices that may be used to confirm the presence or absence of a target analyte without using lab equipment. For the qualitative and quantitative detection of particular antigens and antibodies, these instruments are frequently employed in hospitals and clinical laboratories. It's a low-cost, straightforward method for detecting infections or biomarkers in humans and animals, as well as pollutants and harmful substances in water, food, and animal feed. The COVID-19 pandemic has had a beneficial influence on the lateral flow assays market, since the requirement for quick identification of coronavirus infection has been a priority since the epidemic began in December 2019. As the number of cases has grown across the globe, most of the major lateral flow assay market players have invested in research and development, and formed partnerships and agreements with other market players and government agencies to develop lateral flow diagnostic solutions for the disease. As a result, several COVID-19 antibody and antigen tests have been launched, with excess manufacturing and distribution of these tests across areas to meet increased demand.

Lateral Flow Assays Market: Key Players

Abbott Laboratories (U.S.)

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

Danaher Corporation (U.S.)
F. Hoffmann-La Roche Ltd. (Switzerland)
Siemens Healthineers AG (Germany)
Becton, Dickinson and Company (U.S.)
BioMérieux SA (France)
Bio-Rad Laboratories Inc. (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
QIAGEN N.V. (Germany)
PerkinElmer Inc. (U.S.)
Quidel Corporation (U.S.)
Merck KGAA (Germany)

Growth Factor

High prevalence of infectious diseases across the globe

Despite tremendous advancements in sanitation and medicine, infectious illness incidence remains high over the world. Infectious illnesses are still a major public health problem across the world, despite the fact that non-communicable illnesses are the largest cause of morbidity and mortality. Infectious illnesses take the lives of more than 15 million people worldwide each year, according to the National Institute of Allergy and Infectious Diseases. In the forecast period, this factor is expected to be a significant driver of the lateral flow assays market.

Segmentation

By Product
- Kits & Reagents
- Lateral Flow Readers
- Digital/Mobile Readers
- Benchtop Readers
By Technique
- Sandwich Assays
- Competitive Assays
- Multiplex Detection Assays
By Application
- Clinical Testing
- Infectious Disease Testing
- Cardiac Marker Testing
- Pregnancy & Fertility Testing
- Cholesterol Testing/Lipid Profile
- Drug Abuse Testing
- Other Clinical Tests
- Veterinary Diagnostics
- Food Safety & Environment Testing
- Drug Development & Quality Testing
By End-User
- Hospitals & Clinics
- Diagnostic Laboratories
- Home Care
- Pharmaceutical & Biotechnology Companies
- Other End Users
Lateral Flow Assays Market Dynamics
Lateral Flow Assays Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Lateral Flow Assays Market growth?
Which segment accounted for the largest Lateral Flow Assays Market share?
Who are the key players in the Lateral Flow Assays Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Frequently Asked Questions (FAQ):

lateral flow assays market covers rapid, point-of-care diagnostic tests (such as kits and readers) used to detect various analytes in liquids quickly and easily, often without lab equipment, across healthcare, food safety, veterinary and environmental applications.

Global market was estimated at around USD 9.85 billion in 2024 and is projected to reach approximately USD 13.60 billion by 2030, with a compound annual growth rate (CAGR) of about 6% in the forecast period.

Growth is driven by rising demand for rapid and accessible diagnostics, increasing prevalence of infectious and chronic diseases, growth of point-of-care and home testing settings, and technological advancements such as multiplex testing and digital readers.

Key restraints include limitations of sensitivity and specificity compared to lab-based tests, regulatory and quality-validation hurdles, cost and manufacturing complexity for advanced formats, and competition from alternative diagnostic technologies.

Market is segmented by product (kits & reagents, readers), by application (clinical testing, veterinary, food & environment), by technique (sandwich, competitive, multiplex), and by region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa).